Empire Asset Management Company Initiates Coverage

Jan 31, 2013, 08:43 ET from Empire Asset Management Company

NEW YORK, Jan. 31, 2013 /PRNewswire/ -- Empire Asset Management Company a FINRA member (143007) initiated coverage today on Alnylam Pharmaceuticals Inc, (NASDAQ: ALNY) with a Sell rating and 12 month price target $14.00.

 

SOURCE Empire Asset Management Company